Stay updated on Volitinib for Primary CNS Tumors Clinical Trial
Sign up to get notified when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.

Latest updates to the Volitinib for Primary CNS Tumors Clinical Trial page
- Check7 days agoChange DetectedThe page now indicates the study is no longer recruiting participants. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label was standardized with a revision note (v3.6.0).SummaryDifference0.4%

- Check14 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, signaling a new revision of the page/template.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page’s footer “Revision” was updated from **v3.5.0** to **v3.5.3**, indicating a ClinicalTrials.gov software/version release rather than any change to the study details.SummaryDifference0.0%

- Check71 days agoChange DetectedResults Submitted now appears on the Study Details page, replacing the previous 'No Results Posted' indicator. This signals that results data have been submitted for the study.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page.SummaryDifference0.0%

Stay in the know with updates to Volitinib for Primary CNS Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.